Key result
Distributional reinforcement learning agent achieves ~3% higher sepsis recovery rate vs clinicians.
Why the study?
Sepsis treatment is a challenging high-stakes decision-making problem, where machine learning faces limited, error-afflicted data in a complex biological system alongside the need for robust, transparent, and safe decisions.
Does a distributional reinforcement learning agent improve the recovery rate compared to clinicians in sepsis patients?
Does a distributional reinforcement learning agent improve the recovery rate compared to clinicians in sepsis patients?
Effect estimate: >3% increase
A distributional reinforcement learning model outperformed clinician decision-making in a retrospective dataset of sepsis patients, increasing the simulated recovery rate by over 3%.
Should not change sepsis care; leaves open prospective validation of distributional reinforcement learning.
We present a novel setup for treating sepsis using distributional reinforcement learning (RL). Sepsis is a life-threatening medical emergency. Its treatment is considered to be a challenging high-stakes decision-making problem, which has to procedurally account for risk. Treating sepsis by machine learning algorithms is difficult due to a couple of reasons: There is limited and error-afflicted initial data in a highly complex biological system combined with the need to make robust, transparent and safe decisions. We demonstrate a suitable method that combines data imputation by a kNN model using a custom distance with state representation by discretization using clustering, and that enables superhuman decision-making using speedy Q-learning in the framework of distributional RL. Compared to clinicians, the recovery rate is increased by more than 3% on the test data set. Our results illustrate how risk-aware RL agents can play a decisive role in critical situations such as the treatment of sepsis patients, a situation acerbated due to the COVID-19 pandemic (Martineau 2020). In addition, we emphasize the tractability of the methodology and the learning behavior while addressing some criticisms of the previous work (Komorowski et al. 2018) on this topic.
No takes yet. Share an insight, caveat, or question.
Böck et al. (2022) studied Sepsis. Distributional reinforcement learning (RL) vs. Clinicians was evaluated on Recovery rate (>3% increase). A distributional reinforcement learning agent increased the recovery rate for sepsis by more than 3% compared to clinicians on the MIMIC-III test dataset.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: